Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
The Educational Data Science program is designed to provide you with the essential knowledge and skills you need for this expanding field of data analytics—one of the ten fastest growing occupations ...
XDA Developers on MSN
I used to hate complex spreadsheet formulas and then I found Python in Excel
Excel is my database, Python is my brain.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Do you have a local show production that you'd like to list on BroadwayWorld to help spread the word, sell tickets to your show and to promote your theatre? You've found the right spot. List your show ...
After a shooting at an ICE facility, protesters were charged with attempted murder—then the government added terrorism charges. Rachel Monroe reports on the Trump Administration’s strategy for turning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results